Those who favor indefinite lockdowns believe they have the moral high ground. They do not. In reality, they callously turn a blind eye to the economic and social devastation that their policy is causing.
From vaping to cutting-edge biotechnology, UK health regulators do a far better job than their American counterparts. This was proven yet again when the UK beat the U.S. FDA at approving a coronavirus vaccine produced by Pfizer, an American company.
Reports of an H5N8 influenza virus spreading among birds across the globe understandably have generated concern. However, H5 viruses do not pose a direct threat to the health of the vast majority of humans on the planet, at least not yet.
The infectious period for a COVID patient is thought to be 10-20 days, based on the severity of the disease. One patient, however, was shedding virus for 105 days and was infectious for 70 of them.
From greasy menus to double-dipping, the COVID pandemic will help us say goodbye to some nasty cultural practices.
A new paper attempts to create the best estimate for the COVID infection-fatality rate (IFR), which answers the question, "If I get sick, what is the chance that I will die?" Beware: The virus discriminates.
Opposition to the use of biotechnology to enhance agriculture was always based on junk science. But now these anti-GMO activists look downright silly as cutting-edge biomedical science rescues us from COVID.
Washington State Governor Jay Inslee has canceled Thanksgiving as part of a new COVID lockdown. The Grinch of Whoville couldn't have created a better policy.
There are about 2,000 drugs and vaccines (mostly the former) now in clinical trials. ACSH advisor Dr. Henry Miller argues that to get COVID-19 under control we will need therapeutics no matter how effective vaccines are. Here's why.
We don't have an unlimited supply of diagnostic tests for COVID. So, researchers have developed nine simple questions that can predict whether someone is likely to have the disease.
Europe is in worse shape than the U.S. when it comes to new infections, at least for the time being. Without a change in strategy -- and hoping for a vaccine is not a strategy -- going back into lockdown is pointless, as a third (or fourth) wave will emerge when society reopens.
Remdesivir arrived with great hope and even greater expectations. Would this drug finally awake us from the 2-plus-month long nightmare that has the U.S. tossing and turning in its sleep? As things stand now that answer is no. Here's why.